1. Home
  2. BRDG vs PRTC Comparison

BRDG vs PRTC Comparison

Compare BRDG & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRDG
  • PRTC
  • Stock Information
  • Founded
  • BRDG 2009
  • PRTC 2015
  • Country
  • BRDG United States
  • PRTC United States
  • Employees
  • BRDG N/A
  • PRTC N/A
  • Industry
  • BRDG Investment Managers
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRDG Finance
  • PRTC Health Care
  • Exchange
  • BRDG Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • BRDG 391.6M
  • PRTC 439.8M
  • IPO Year
  • BRDG 2021
  • PRTC N/A
  • Fundamental
  • Price
  • BRDG $10.21
  • PRTC N/A
  • Analyst Decision
  • BRDG Hold
  • PRTC Buy
  • Analyst Count
  • BRDG 5
  • PRTC 1
  • Target Price
  • BRDG $11.30
  • PRTC $45.00
  • AVG Volume (30 Days)
  • BRDG 438.3K
  • PRTC 5.9K
  • Earning Date
  • BRDG 08-05-2025
  • PRTC 08-27-2025
  • Dividend Yield
  • BRDG 4.11%
  • PRTC N/A
  • EPS Growth
  • BRDG N/A
  • PRTC N/A
  • EPS
  • BRDG N/A
  • PRTC 0.21
  • Revenue
  • BRDG $453,729,000.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • BRDG N/A
  • PRTC $35.98
  • Revenue Next Year
  • BRDG $36.21
  • PRTC $115.38
  • P/E Ratio
  • BRDG N/A
  • PRTC $7.88
  • Revenue Growth
  • BRDG 39.05
  • PRTC 44.98
  • 52 Week Low
  • BRDG $7.09
  • PRTC $13.30
  • 52 Week High
  • BRDG $11.69
  • PRTC $25.00
  • Technical
  • Relative Strength Index (RSI)
  • BRDG 64.96
  • PRTC 51.10
  • Support Level
  • BRDG $9.84
  • PRTC $17.09
  • Resistance Level
  • BRDG $10.21
  • PRTC $18.40
  • Average True Range (ATR)
  • BRDG 0.25
  • PRTC 0.45
  • MACD
  • BRDG 0.07
  • PRTC -0.10
  • Stochastic Oscillator
  • BRDG 96.49
  • PRTC 48.55

About BRDG Bridge Investment Group Holdings Inc.

Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The Company operates as one business, a fully integrated real estate investment manager.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: